|
2025
|
P/S
|
Pharmaceutical preparations for treatment of dermatological conditions, diseases, and disorders |
|
|
Invention
|
Anhydrous compositions of mtor inhibitors and methods of use.
Disclosed herein are compositions ... |
|
2023
|
Invention
|
Anhydrous compositions of mtor inhibitors and methods of use. Disclosed herein are compositions a... |
|
|
P/S
|
Chemical drug delivery agent in the form of a semi-solid dissolvable medical gel that facilitates... |
|
|
P/S
|
Chemical drug delivery agent in the form of a semi-solid
dissolvable medical gel that facilitate... |
|
2022
|
Invention
|
Compositions of rapamycin and their use in the treatment of microcystic lymphatic malformation.
... |
|
|
Invention
|
Compositions of rapamycin and their use in the treatment of microcystic lymphatic malformation. E... |
|
|
Invention
|
Anhydrous compositions of egfr inhibitors and methods of use.
Disclosed herein are compositions ... |
|
|
Invention
|
Anhydrous compositions of egfr inhibitors and methods of use. Disclosed herein are compositions a... |
|
|
Invention
|
Methods and compositions for treating gorlin syndrome.
Disclosed herein are compositions and met... |
|
|
Invention
|
Methods and compositions for treating gorlin syndrome. Disclosed herein are compositions and meth... |
|
2020
|
Invention
|
Methods of treating keratin hyperproliferation disorders using mtor inhibitors. A method of treat... |
|
2018
|
Invention
|
Anyhydrous compositions of mtor inhibitors and methods of use. Disclosed herein are compositions ... |
|
2017
|
Invention
|
Methods of treating keratin hyperproliferation disorders using mtor inhibitors.
A method of trea... |
|
2015
|
Invention
|
Methods of treating pain and/or itch with small molecule inhibitors targeting an mtor pathway.
M... |
|
2014
|
Invention
|
Compositions for transdermal delivery of mtor inhibitors. 20 fatty acid; and a base. |
